English | Español
Patient Daily | Apr 17, 2026

Replimune faces layoffs and site closures after FDA rejects melanoma drug again
Patient Daily | Apr 17, 2026

USP adds Tamiflu and Trulicity to list of drugs vulnerable to supply disruptions
Patient Daily | Apr 16, 2026

Podcast discusses the future of funding in European biotech sector
Patient Daily | Apr 16, 2026

Health Analyst: Abuse of 340b drug discount program ‘leaves patients stuck in the middle’

Patient Daily | Apr 16, 2026

AGC Biologics outlines benefits of modular bioreactors for flexible drug manufacturing
Patient Daily | Apr 16, 2026

FDA’s transparency policy on rejection letters changes biopharma communication practices
Patient Daily | Apr 16, 2026

Revolution Medicines reports pancreatic cancer drug doubles survival in late-stage trial
Patient Daily | Apr 16, 2026

Allogene reports early success for cell therapy in lymphoma trial interim analysis

Trending
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions